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Abstract
Genomics has produced hundreds of new hemoglobin sequences with examples in nearly every living organism. Structural
and biochemical characterizations of many recombinant proteins reveal reactions, like oxygen binding and NO
dioxygenation, that appear general to the hemoglobin superfamily regardless of whether they are related to physiological
function. Despite considerable attention to ‘‘hexacoordinate’’ hemoglobins, which are found in nearly every plant and
animal, no clear physiological role(s) has been assigned to them in any species. One popular and relevant hypothesis for
their function is protection against NO. Here we have tested a comprehensive representation of hexacoordinate
hemoglobins from plants (rice hemoglobin), animals (neuroglobin and cytoglobin), and bacteria (Synechocystis hemoglobin)
for their abilities to scavenge NO compared to myoglobin. Our experiments include in vitro comparisons of NO
dioxygenation, ferric NO binding, NO-induced reduction, NO scavenging with an artificial reduction system, and the ability
to substitute for a known NO scavenger (flavohemoglobin) in E. coli. We conclude that none of these tests reveal any
distinguishing predisposition toward a role in NO scavenging for the hxHbs, but that any hemoglobin could likely serve this
role in the presence of a mechanism for heme iron re-reduction. Hence, future research to test the role of Hbs in NO
scavenging would benefit more from the identification of cognate reductases than from in vitro analysis of NO and O2
binding.
Citation: Smagghe BJ, Trent JT, Hargrove MS (2008) NO Dioxygenase Activity in Hemoglobins Is Ubiquitous In Vitro, but Limited by Reduction In Vivo. PLoS
ONE 3(4): e2039. doi:10.1371/journal.pone.0002039
Editor: Harald H. H. W. Schmidt, Monash University, Australia
Received January 7, 2008; Accepted February 3, 2008; Published April 30, 2008
Copyright:  2008 Smagghe et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was made possible by the National Institutes of Health Award R01-GM065948, support from the Iowa State University Plant Sciences
Institute, by a ‘Contrat Plan-Etat-Re ´gion’ to the Laboratoire ‘‘Stress abiotiques et differenciation des ve ´ge ´taux cultive ´s’’, and by a doctoral fellowship of the ‘Conseil
Re ´gional du Nord-Pas de Calais’.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: msh@iastate.edu
¤ Current address: CBR Institute for Biomedical Research, Boston, Massachusetts, United States of America
Introduction
Hemoglobins (Hbs) became a focus of study early in the history
of biochemistry, due to their color and ready availability in red
blood cells and muscle. An unambiguous role facilitating
respiration through oxygen transport made red blood cell Hb
the first protein for which a physiological function was understood
[1]. A clear physiological role in combination with facile structural
analysis has made oxygen transport Hbs ideal models for those
seeking to learn the biophysical details relating protein structure
and function [2,3]. Recent years however, have seen new Hb
discoveries that challenge many paradigms in this field, including
that of their predominant function as oxygen transporters. For
example, it is clear that red blood cell Hb and Mb also play
important roles in NO homeostasis [4–7].
Genomics studies have generated hundreds of new globin
sequences and revealed this family of proteins as being nearly
ubiquitous among living organisms [8–10]. Hexacoordinate Hbs
(hxHbs) are a structurally unique subset of the Hb superfamily that
display reversible coordination of the heme iron ligand-binding
site by an intramolecular histidine side chain [11–14]. Prominent
members of this group include neuroglobin and cytoglobin from
humans and other animals [9,11,12,15–17], the nonsymbiotic
plant Hbs (nsHbs) found in all plants [14], and the cyanobacterial
protein cyanoglobin [18,19]. The diverse and prevalent distribu-
tion of hxHbs among organisms is often coupled with their high
cross-species sequence identity, suggesting proteins with critical
physiological roles. Current hypothesis suggest they might provide
a common mechanism for protecting cells against hypoxia and
oxidative chemistry in plants and animals. Despite numerous
publications describing the significant structural and biophysical
effort directed at these proteins [11–13,19–25], a solid assignment
of their physiological role(s) remains elusive [8,14,26].
While many enzymes exhibit exquisite efficiency and specificity
in the catalysis of their reactions, the innate chemistry of the heme
prosthetic group is more ‘‘promiscuous’’ in nature, conferring Hbs
with several reactivities of potential in vivo significance. These vary
from reversible binding of diatomic ligands (including O2, CO,
NO, and many anions) [2,27], to peroxidase activity [28,29], and
redox reactions [14]. Studies of such reactions have served to focus
significant attention on putative functions of newly discovered Hbs
involving nitric oxide (NO) binding and/or scavenging [30–34].
Such studies include the measurement of NO reactions with
hxHbs in the oxy [33,35,36], ferric and ferrous protein forms
[37,38], as well as characterization of peroxynitrite reactions with
some ferrous-NO hxHb [38,39].
Two reaction mechanisms have been proposed for the
scavenging of NO by heme proteins. Mb and red blood cell Hb
destroy NO using the ‘‘NO dioxygenase’’ (NOD) reaction (Figure 1
#1) in which the oxy-Hb rapidly reacts with NO to form ferric Hb
PLoS ONE | www.plosone.org 1 April 2008 | Volume 3 | Issue 4 | e2039and nitrate [40,41]. In fact, even when ferrous NO-Hb is reacted
with O2, the rate limit to heme oxidation is NO dissociation,
which is rapidly followed by O2 binding to the heme iron and a
subsequent NOD reaction (49). Initially it was reported that the
bacterial and yeast flavohemoglobins (flavoHbs) use the NOD
mechanism in their reactions [42–46]. Alternatively, it has been
proposed that the flavoHbs use an ‘‘O2 denitroxylase’’ mechanism
(Figure 1 #4), in which NO binding precedes a reaction between
the NO-heme complex and oxygen [47–49]. In either case, the
resulting oxidized heme must be reduced to start the reaction over
(Figure 1, #5). For flavoHbs, rapid reduction is achieved through
a flavin-containing reductase domain [50–54].
Because of the change in heme oxidation state that accompanies
NO reactions with Hbs, reduction reactions have been a recent
focus of research [55–57]. The kinetics of the reduction reaction is
not as critical in NO scavenging by red blood cell Hb or Mb, as
these proteins are present in vast stoichiometric excess compared
to NO. However, with the possible exception of neuroglobin in the
retina [58], hxHbs are present in very low (sub-micromolar)
concentrations in the organisms in which they have been identified
[14,26]. Thus, if they were to serve catalytic roles in NO
scavenging, efficient mechanisms for reduction would be needed.
However, cognate reductases suitable for reduction on flavoHb
time scales have yet to be assigned for any hxHb and reduction
mechanisms are still unknown. Thus an important question to ask
for hxHbs is whether reduction is truly the rate limiting step for
catalytic NO scavenging. Ferric Hbs can also bind NO (Figure 1,
#2) and, as bound NO can potentially reduce the heme iron
(Figure 1, #3) [38,59], ferric NO reactions and NO-reduction
must be evaluated for hxHbs as well.
The purpose of the research reported here is to systematically
compare NO reactions with a representative set of hxHbs to Mb,
with the underlying goal of testing whether these reactions
distinguish any of the hxHbs in their ability to bind or destroy
NO. The importance of this comparison centers on the premise
that if we are justified in using in vitro reactions to assign NO
binding functions in hxHbs, we should expect some characteristic
to distinguish a hxHb from Mb, which does not catalyze NO
destruction absent a reductase. Here we compare NO scavenging
in vitro and in flavoHb knockout E. coli cells and ferric NO
reactions with human neuroglobin (Ngb) and cytoglobin (Cgb),
rice nsHb (riceHb1), Synechocystis hemoglobin (cyanoglobin,
SynHb), and horse heart Mb. Our results demonstrate that all of
these oxyHbs can rapidly destroy NO in vitro at a rate equal to re-
reduction of the ferric Hb, all bind NO in the ferric form, all but
ferric SynHb are slowly reduced by NO, but only the bacterial
hxHb can replace flavoHb function in vivo.
Materials and Methods
Protein production and purification
Human neuroglobin (Ngb, GenBank accession number
Q9NPG2) and cytoglobin (Cgb, GenBank accession number
Q8WWM9), rice nsHb (riceHb1, GenBank accession number
O04986) and Synechocystis hemoglobin (SynHb, GenBank accession
number BAA17991) were expressed and purified as described
previously [22]. Horse heart myoglobin was commercially obtained
(Sigma), dissolved in 0.1 M potassium phosphate (pH 7.0) to
generate a 2 mM stock, and desalted over a G-25 column. This
procedure yielded a sample giving a single band on SDS PAGE with
kineticand spectral properties identical to those previously published
[2]. Prior to experiments, allproteins were oxidized with an excessof
potassium ferricyanide, which was removed by passage through a
Sephadex G-25 column equilibrated in 0.01M potassium phosphate
(pH 7.0).Theferredoxin-NADP reductasegene(GenBankaccession
number AAC76906) was amplified by PCR from Escherichia coli.T h e
oligonucleotide sequences were: 59CCTGGTGCCGCGCGGC-
AGCCATATGGCTGATTGGGTAACAGGCAAAG–39 and 59-
TTGTCGACGGAGCTCGAATTCTTACCAGTAATGCTCC-
GCTGTC-39. Amplification was done by 35 cycles of 30s at 95uC,
30s at 55uCa n d1m i na t7 2 uC. The resulting fragment was then
cloned in the pET28a plasmid (Novagen) between the NdeI and
EcoRI restriction sites. The His-Tagged protein was expressed and
purified as described earlier [22].
UV/VIS spectroscopy
The NO-ferric spectra were recorded by mixing a deoxygenated
ferric Hb solution (5 mM) with a 2 mM NO solution. The NO-
ferrous spectra were recorded by addition of a 2 mM NO solution
(1mM final) to a sodium dithionite reduced protein solution, in a
cuvette previously sparged with N2. To follow the NO-induced
reduction of the protein, spectra were collected over a period of 5h
after mixing.
First attempts to measure ferric NO binding displayed non-
saturated spectrum at low NO concentrations. Therefore, NO
binding was measured by equilibrium titration of 5 mM Hb with
NO solutions (7 mM to 2 mM). The dissociation equilibrium
constants (KD NO, Fe3+) for each protein (Table 1) were extracted
using the following equation where FB is the fraction of NO-bound
protein:
FB~
½NO 
KDNO,Fe 3zz½NO 
ðEquation 1Þ
The saturated NO solution (2 mM) was prepared by equili-
brating a buffer solution with NO gas that was first passed through
a 20% NaOH solution [60]. All spectra were recorded using a
Varian Cary 50 spectrophotometer at room temperature. All
solutions were made with 0.1 M potassium phosphate buffer
pH 7.0.
NO dioxygenation and scavenging in vitro
A multi-port measurement chamber (World Precision Instru-
ments, WPI. Sarasota, Fl) was used to analyze the stoichiometric
reaction between oxyferrous hxHb and NO at room temperature.
The chamber contained 0.1 M potassium phosphate pH 7.0 and
was equilibrated with N2. The low oxygen concentration was
measured using an oxygen electrode (ISO-OXY-2, WPI). At 0%
oxygen, the chamber was closed leaving a small dead space
(0.5 cm) at the surface of the solution flushed with N2. Then
20 mM NO was added and the signal was followed using a NO
Figure 1. NO reactions with hemoglobins. 1, NO dioxygenase
activity; 2, NO binding to the ferric Hbs; 3, NO-induced heme iron
reduction; 4, O2 nitroxylase activity; 5, reduction reaction of ferric Hbs (4).
doi:10.1371/journal.pone.0002039.g001
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oxyferrous Hb (20 mM final concentration) was added to the
solution and the decay of the NO signal was recorded.
Rapid mixing experiments measuring NOD rate constants have
been described earlier [40] and were conducted with a BioLogic
SFM 400 stopped-flow reactor coupled to a MOS 250
spectrophotometer. Ferric protein was reduced using a system
adapted from an earlier study [61] in an Eppendorf sparged with
N2. After 10 min, each ferrous protein sample was added to a gas
tight syringe containing 0.1 M potassium phosphate pH 7.0
(262 mMO 2). The oxygen bound protein (1 to 5 mM, after
mixing) was confirmed by recording the oxy-ferrous spectrum.
The NO solutions were generated by mixing a saturated NO
solution (2 mM) with a N2 equilibrated potassium phosphate
buffer (0.1 M, pH 7.0) in gas tight syringes. An anaerobic
condition in the NO syringes was maintained using the glucose
oxidase-catalse system [35]. Kinetic time courses were collected
(20uC) at different NO concentrations (5 to 500 mM) by recording
the change in absorbance at a fixed wavelength (413 for Mb, 422
for Ngb/Cgb and 420 for riceHb1). Between five and eight kinetic
traces were collected and averaged for each time course.
Ferric NO binding
Rapid mixing experiments measuring NO binding to the ferric
protein were conducted with a BioLogic SFM 400 stopped-flow
reactor coupled to a MOS 250 spectrophotometer. Two syringes
were used: one containing the protein solution (Fe
3+, ,5 mM after
mixing) and the other containing an NO solution. Reaction
concentrations above 1 mM [NO] were obtained by mixing a
larger volume of the saturated NO solution than volume of Hb.
Anaerobic condition in the NO syringes were maintained using
the glucose oxidase-catalse system [35]. Kinetics time courses were
collected (20uC) at different NO concentrations by recording the
change in absorbance at a fixed wavelength (Soret peak). At least
three kinetic traces were collected and averaged. The minimal NO
concentration was at least 2 times higher than the calculated
KD NO, Fe3+ (Table 1).
Enzymatic reduction of hxHbs
The reduction system used in the present study has been
adapted from one described in detail previously [61]. First a 1 ml
cuvette was flushed for 1 min with 1 atm CO. Then 0.1 M
potassium phosphate pH 7.0 equilibrated with 1 atm CO was
added through a rubber stopper. After addition of 60 mM NADP
+
(Sigma, St. Louis, MO), 0.7 U/ml glucose-6-phosphate (G6P)
dehydrogenase (Roche, Pleasanton, CA), 1 mM ferredoxin-NADP
reductase (E. coli) and 5 mM Hb, 3mM G6P was added to start the
reduction reaction. Absorbance spectra were collected over a
period of 30 min at room temperature. The difference in
absorbance between ferric and CO-bound protein was plotted
versus time to calculate the initial velocity of the reaction.
Catalytic NO consumption experiments
The multi-port measurement chamber (WPI) containing 0.1 M
potassium phosphate pH 7.0 and 3mM G6P, was first equilibrated
with a mixture N2/O2 to reach an O2 concentration of 4%, as
measured with an oxygen electrode (ISO-OXY-2, WPI). At 4%
O2, the chamber was closed leaving a small dead space (0.5 cm) at
the surface of the solution. Then, 10 mM Hb, 60 mM NADP
+
(Sigma, St. Louis, MO), 0.7 U/ml glucose-6-phosphate (G6P)
dehydrogenase (Roche, Pleasanton, CA), and 1 mM ferredoxin-
NADP reductase (E. coli) was added to the solution to make the
ferrous-oxy complex. After 10 min, 40 mM NO was added to the
solution and its removal was measured using the NO electrode
(ISO-NOP, WPI) at room temperature. The NO consumption
rate (Table 1) was calculated from the initial velocity just after NO
addition.
NO scavenging in flavoHb knockout E. coli
E.coli strains AB1157 [42] and AG1000 ((AB1157W (hmp-
lacZ)262; Cm
r)) were generously provided by Dr Paul Gardner
(Cincinnati Children’s Hospital Medical Center). All Hbs were
cloned into the pANX plasmid between the NdeI and HindIII
restriction site except sperm whale myoglobin, which was cloned
between the NdeI and BamHI restriction sites. The pANX
plasmid is derived from pUC19 and contains the promoter region
of the hmp gene of E. coli [62]. The expression of a gene cloned
next to it (via NdeI), will be driven by that promoter and should be
comparable to the natural hmp gene expression. The generated
plasmids were transformed into the hmp deficient strain AG1000.
As a control, ‘‘virgin’’ pANX and pANX-hmp (provided by Dr
Paul Gardner) were also transformed into AG1000.
A test tube containing 5 ml LB medium was inoculated with 1%
of an overnight culture grown aerobically. No selection was used
for the AB1157 strain. For the AG1000 strain, 27 g/ml
chloramphenicol was added to the medium, and for AG1000
containing the different plasmids, 50 mg/ml carbenicillin was also
added. After inoculation of the test tubes (,0.02 OD600), 3 mM
GSNO was added and the cultures were grown aerobically at
37uC with constant agitation. The concentration of GSNO used in
these experiments was determined by the minimum level necessary
to reveal a clear hmp- phenotype in our reactions. (and is
comparable to those used by others in NO challenge experiments).
After 14 hours the OD600 was measured. As a control, cells were
grown without GSNO and in the presence of 3 mM inactivated
GSNO (as described in the Supplemental Figure S1.) Untreated
Table 1. Kinetic and affinity values for in vitro reactions with NO and heme iron reduction.
kobs, NOD
KDNO (Fe3+)
mM
kobs,NO (Fe3+)
mM
21s
21
kred,NO
min
21
kcat vs FdR
min
21
Km vs FdR
mM
Observed Hb
reduction mM/min
21
Observed NO
consumption mM/min
21
Mb 34 (mM
21s
21) 262 70 0.03 5 17 2 3.2
RiceHb1 90
* (s
21) 42 3.5 0.0006 5 20 1.6 2.9
Ngb 360
* (s
21) 75 2 0.12 6 17 1.9 2.7
Cgb 430
* (s
21) 17 13 0.05 9 21 2.7 5.3
SynHb na 370 0.073 ,0 5 12 2.4 2.2
*: maximal observed rate of NOD
doi:10.1371/journal.pone.0002039.t001
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results shown are an average of three independent experiments,
repeated once.
GSNO was generated by mixing a stoichiometric amount of
reduced gluthathione (Sigma) and acidified sodium nitrite for
10 min in the dark [63]. Then the pH was adjusted to 7.4 with 4N
sodium hydroxide. The concentration of GSNO was determined
using e334=767 M
21cm
21 [64]. As control, to test if the effect
observed is due to NO alone or to other by-products produced
during its synthesis, we destroyed the NO component of our
GSNO by photolysis [65]. To do this, the GSNO solution
(,0.2 M) was placed in a 4 ml cuvette and photolyzed using a
YAG laser (532 nm). After 45 min all GSNO was inactivated, and
NO released during that process was neutralized by pure oxygen
during a 15 min exposure. These experiments are provided in
Supplemental Figure S1.
Measurement of hemoglobin expression levels in vivo
Saturated cultures, inoculated from an overnight culture, were
used to measure the expression level for each Hb. For SynHb, cells
treated overnight with 3 mM GSNO were also used. Cells were
harvested by centrifugation at 6000 rpm for 6 min. The cell pellet
was then resuspended in 0.1 M potassium phosphate pH 7.0 and
sonicated (3630s with ,5 min interval). After centrifugation to
remove the cell debris (20000 rpm for 30 min), the supernatant
(50 mg/ml total protein) was used to record CO+sodium
dithionite–reduced sodium dithionite difference spectra. The
difference spectrum of each protein was corrected by the
difference spectrum measured with the supernatant of the strain
transformed with pANX alone. The results shown are an average
of two independent experiments.
Measurement of NO consumption in vivo
The multi-port measurement chamber (WPI) containing air
equilibrated 0.1 M phosphate pH 7.0 was used for the aerobic
NO consumption, at room temperature, of the different E. coli
strains. NO (2 mM) was added to the chamber, and when the
signal reached a maximum (as measured with the NO electrode
(ISO-NOP, WPI)) cells were added (1610
7 cells/ml) from an
overnight culture. For SynHb, cells treated overnight with 3 mM
GSNO were also used. The rate of consumption was calculated as
the time required to consume 1 mM (half the signal) of NO. All
rates were corrected for the rate of consumption by the strain
transformed with pANX alone. The results shown are an average
of six independent experiments, repeated once.
Results
NO dioxygenation and non-catalytic NO consumption
The rate constant for NOD by Mb has been reported previously
[40]. It is a very rapid (nearly diffusion limited), bimolecular
reaction between NO and the oxy-Hb complex. While peroxyni-
trite is considered to be an intermediate in this reaction (Figure 1,
#1) [66], its dissociation rate is not limited in Mb over the range of
NO concentrations amenable to stopped flow kinetics [40]. All of
the oxy-hxHbs react with NO, and NOD by Ngb and a plant
nsHb has been reported previously [35,67,68]. In the case of
mouse Ngb, the reaction displayed similar kinetics at the two [NO]
tested [35]. The interpretation of this observation was that
dissociation of peroxynitrite is rate limiting. Each hxHb investi-
gated here, over a range of NO concentrations, showed saturating
kinetics as [NO] increased, but the limiting observed rate constant
varies between proteins (Figure 2A). Ngb and Cgb are similar
(kobs, NOD=360 and 430 s
21, respectively), but riceHb1 is slower
(kobs, NOD=90s
21) (Table 1). Unfortunately, we were not able to
calculate the rate constant for SynHb as the change in absorbance
was very small, resulting in very noisy time courses.
Ferric NO binding and NO-induced reduction
Human Ngb is the only ferric hxHb for which reactions with
NO have been published [38]. Binding was very slow, and
produced ferrous NO-Ngb. Figure 3 shows the [NO] dependence
of the observed rate constant following mixing with each ferric
hxHb and Mb. Mb binds NO in a bimolecular fashion, with an
observed rate constant equal to 70 mM
21 s
21. In the case of each
hxHb, time courses for binding also display a linear dependence
on [NO], but the observed bimolecular rate constants are much
smaller (kobs,NO(Fe3+), Table 1).
NO reduction of ferric Hbs has been reported extensively for
Mb [59,69], and as described above for Ngb [38]. Following the
NO binding reactions in Figure 3 (particularly those at higher
[NO]), relatively slow reduction of some of the ferric Hbs by NO
was observed (Figure 4A–E). The degree to which this reaction can
regenerate ferrous Hb was gauged by calculating the fraction of
Figure 2. NO dioxygenation and stoichiometric NO consump-
tion.Plotsofkobs,NODvs[NO]fortheNODreactionfollowingrapidmixing.
doi:10.1371/journal.pone.0002039.g002
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Cgb showed significant reduction over this time period. Time
courses for this reaction yielded rate constants (kred,NO) of 0.03,
0.12 and 0.05 min
21 for Mb, Ngb and Cgb, respectively (Table 1).
For riceHb1, the rate constant was estimated to be 0.006 min
21
(following a 5h time course). Ferric SynHb showed no significant
reduction by NO.
Catalytic NO scavenging
We have demonstrated that each oxy-hxHb has the ability to
carry out the NOD reaction with varying degrees of efficiency
(Figure 2 and Table 1). However, to scavenge NO catalytically, re-
reduction of the resulting ferric heme iron must occur (Figure 1,
#5). In Figure 5, the contribution of heme iron reduction to NO
scavenging is investigated by using an artificial reductase system
(ferredoxin-NADP reductase (FdR) from E. coli) that reacts with
similar effectiveness with each hxHb under investigation. Figure 5A
provides an example of the spectral changes associated with
reduction of ferric Ngb by this system and in the presence of CO
(which serves to trap the reduced Hb). Figure 5B shows time
courses for reduction of each hxHb (10 mM) by 1 mM FdR, and
the effect of substrate concentration (Hb) on reduction velocity is
shown in Figure 5C. The plots have enough curvature to allow
calculation of kcat and KM for each protein (Table 1). KM and kcat
are similar for each Hb, with none deviating by more that 2-fold
from the others.
Figure 5D demonstrates catalytic NO scavenging in the FdR/
Hb system described above. With no Hb present, NO is degraded
to 20 mMi n,5 minutes, and the NO signal reaches the initial
baseline value over a period of about 30 minutes. The presence of
10 mM oxy-Hbs accelerates NO removal in a bimodal manner.
First, 25% of the signal (10 mM of the NO) is lost rapidly due to
stoichiometric NOD. The remaining signal decays linearly back to
the background level more rapidly than in the absence of Hb. This
rate of NO destruction is attributed to NOD following ferric Hb
re-reduction and oxygen binding. In fact, the velocities of NO
consumption are nearly identical to the reduction velocities under
these experimental conditions (last two columns, Table 1).
Therefore, the ability of each hxHb and Mb to catalytically
scavenge NO is directly related to the rate of re-reduction of the
heme iron following NOD.
NO scavenging by hxHbs in vivo
The only Hbs that are known to be NO scavengers are the
bacterial and yeast flavoHbs [42,70–73], and the E. coli hmp
(flavoHb) null mutant presents a clear NO-sensitive phenotype
under aerobic conditions [42,74]. The experiments in Figure 6
were designed to test the ability of Mb and hxHbs to substitute for
flavoHb in hmp knockout cells under similar conditions. The
foreign Hbs were introduced into the hmp mutant cells (AG1000)
on a plasmid (pANX) containing the hmp promoter, and cell
growth was measured in the presence and absence of NO donated
by GSNO. GSNO is a NO-releasing agent with properties
comparable to spermine/NO or SNAP [75], and was chosen as an
NO donor because of its documented ability to up-regulate
expression of hmp [76–78] and therefore expression of the Hbs
under the control of the hmp promoter on the pANX plasmid. As a
precaution, to ensure that the effects we observed were due to NO
and not a byproduct of GSNO, ‘‘NO depleted’’ GSNO was also
used as a negative control (this procedure is described in the
Materials and Methods section and Supplemental Figure S1).
Figure 6A presents OD600 values for uniformly-grown E. coli
cultures after 14 hours [79] showing a comparison of cultures
grown in the absence of GSNO, presence of 3 mM GSNO, or the
presence of 3 mM GSNO depleted of NO by photolysis. As
expected, the wild type strain (AB1157) and the hmp mutant strain
(AG1000) expressing flavoHb on the pANX plasmid are able to
grow in the presence of GSNO, but the AG1000 strain alone and
that carrying the empty pANX plasmid are impaired. However,
no protection was observed with the AG1000 strains expressing
Mb or other hxHbs except the one expressing SynHb. In the case
of SynHb, cell growth over this time period was indistinguishable
from AG1000 expressing flavoHb. The different strains were not
sensitive to inactivated GSNO, indicating that the effects observed
in the presence of GSNO are only due to the release of NO and
not to other compounds present in the GSNO solution.
To investigate whether the results in Figure 6A are attributable
to variation in hxHb expression levels in the different strains,
expression was measured independently by recording the CO-
difference spectrum of each [80]. The level of expression is
correlated with the maximum absorbance of the difference
between the cell extract (supernatant) with and without addition
of CO and sodium dithionite. Figure 6B and Table 2 report these
values. From these data it is evident that expression levels vary
significantly, with Ngb being poorly expressed and Mb/SynHb
being expressed at the highest concentrations. Compared to
flavoHb, RiceHb1 and Cgb are expressed 2 to 4 times less, and
Mb and SynHb almost 3 times more.
NO consumption by these cultures was also measured directly
to ensure that it correlates with cell viability. Figure 6C shows rates
of NO consumption by strains containing each Hb on the pANX
plasmid. Rates of consumption by the hxHbs are at least 5 times
slower than flavoHb, even for Mb and SynHb, which are expressed
at the highest levels (Table 2). It was surprising that cultures
expressing SynHb did not consume NO, as they were viable in the
growth experiments presented in Figure 6A, suggesting that SynHb
in the pANX system can protect against NO without consuming it
from the media.
This discrepancy was investigated by monitoring cell growth as
a function of time (Figure 6D). In the absence of GSNO, all
cultures grew at about the same rate. In the presence of 3 mM
Figure 3. NO binding to ferric Mb and hxHbs. Plots of kobs versus
[NO] for Mb and each hxHb. Time courses giving rise to these values
were measured at different [NO] ranging from 50 to 1700 mM (after
mixing) and were fitted to a single exponential to extract the observed
rate constants (kobs). A linear fit of these data provides the observed
ferric NO binding association rate constant (kobs, NO(Fe3+)).
doi:10.1371/journal.pone.0002039.g003
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others (with the exception of SynHb) did not grow. Growth of the
SynHb/pANX culture was retarded, but recovered after ,6 hours
to eventually yield the OD600 values in Figure 6A that are
indistinguishable from those of the Hmp strains. Furthermore, the
GSNO treated SynHb/pANX culture (14h) was capable of more
efficient NO consumption (Figure 6C), but did not show increased
concentration of SynHb (Figure 6B).
Discussion
Ferric hxHbs do not efficiently catalyze NO destruction
It has been proposed that hxHbs might destroy NO through a
mechanism that includes binding to the ferric heme iron [38]. In
the absence of specific reduction mechanisms, this route is
compelling due to the potential for NO to reduce the heme,
which could then bind oxygen and go through one cycle of NO-
dioxygenase activity to reform the starting ferric Hb complex. One
complete cycle would scavenge two molecules of NO using two
different chemical mechanisms. The results presented in Figures 3
and 4, and Table 1 do not support this hypothesis for any of the
hxHbs investigated here. There are at least two kinetic hurdles for
this mechanism; both ferric NO binding and NO-induced
reduction must be fast. We have demonstrated that binding of
NO to ferric hxHbs is significantly slower than to Mb. This is
probably due to intramolecular His binding to the ligand binding
site, which is enhanced in the ferric oxidation state [81]. The
linear dependence of the reaction with [NO] combined with small
observed second-order rate constants (kobsNO, Fe3+ in Table 1) is
indicative of a bimolecular association rate constant for binding to
the pentacoordinate complex that is much slower than the rate
constants for His binding and dissociation [22]. The combination
Figure 4. Absorbance spectra associated with NO-induced reduction. Panels (A–E) show the Hb(3+) (thick solid line), Hb(3+)-NO (dotted
line), Hb(2+)-NO (thin dotted line) absorbance spectra, and the spectrum of the sample 30 minutes after mixing NO with ferric protein (dashed line).
Ferric and ferrous oxidation states are indicated by 3+ and 2+, respectively. F. Percentage of Hb(2+)-NO after 30 minutes of reduction.
doi:10.1371/journal.pone.0002039.g004
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very slow NO association relative to flavoHbs under the same
conditions [44].
An additional factor diminishing the likelihood of the ferric NO-
binding mechanism is the slow rate of reduction of the Hb(3+)-NO
complex. Although this reaction clearly varied between the hxHbs
tested, none exhibited rates capable of rapid NO destruction even
when [NO] is sufficient to saturate the ferric complexes. The
fastest reduction was observed in Ngb, where a reaction half-life of
,6 minutes requires ,1 mM NO to achieve. This does not
support NO reduction of ferric hxHbs as a plausible mechanism
for NO scavenging in vivo where [NO] rarely exceed ,200 nM
[82,83]. However, it could be sufficient to generate ferrous NO-
Ngb for scavenging of peroxynitrite, preventing its deleterious
reaction with CO2 [38], or for O2-nitroxylase mediated NO
scavenging under microaerobic conditions [47].
HxHbs as NO dioxygenases
In this comparative study of Hb NOD, we find no indication
that hxHbs are more efficient in this function than Mb. Instead,
we observe a limiting reaction in hxHbs that is probably
peroxynitrite dissociation [35] (Figure 2). Hence, Mb would
perform better in a NO scavenging role utilizing this reaction
mechanism. However, we have also demonstrated that the limiting
factor in NO scavenging for all Hbs examined is the re-reduction
following NOD (Figure 5D, Table 1). Studies showing that
monohydroascorbate reductase increases the NOD activity of
barley nsHb [84], and that the isolated Hb domain from E. coli
flavoHb is insufficient to protect cells during NO challenge [80],
are in agreement with our results. Thus assignment of NO
dioxygenase activity as a physiological function requires the design
of experiments that address reduction mechanisms.
The E. coli flavoHb reductase domain and the cognate reductase
identified for Vitreoscilla Hb satisfy this requirement in work
attributing physiological relevance to their NOD activity [50,85].
However, in the cases of most non-oxygen transport Hbs
(including those investigated here), such reductases have not been
identified. For example, a ‘‘nitric oxide activated deoxygenase’’
function has been attributed to Ascaris Hb based on in vitro
experiments using NADPH at pH 6.0 to achieve reduction [36].
In this case, these reaction conditions are known to reduce Hbs
nonspecifically [86], and would likely endow several Hbs including
Figure 5. Enzymatic reduction by ferredoxin-NADP reductase and catalytic NO consumption. A. Absorption spectra associated with the
reduction of Ngb (10 mM) by 1 mM ferredoxin-NADP reductase in the presence of CO (1 mM). B. Change in absorbance at the Soret peak (CO-bound)
associated with the reduction is plotted vs time for each Hb (10 mM). The data are normalized to the absorbance change expected for complete
reduction of the Hb in question. C. Enzymatic reduction of Mb and hxHbs by ferredoxin-NADP reductase. V/[ET] calculated at different Hb
concentration is plotted vs [Hb]. The fit to the Michaelis-Menten equation gives Km and Vmax for reduction of each protein. D. Consumption of
40 mMN Ob y1 0mM oxyHb as measured by an NO electrode, in the presence of ferredoxin-NADP reductase (1 mM). For each protein, after addition of
NO, the signal drops by ,10 mM corresponding to stoichiometric NOD. [NO] then decreases linearly indicating catalytic NO destruction. Rates of
consumption were calculated from the linear phase of catalytic NO removal.
doi:10.1371/journal.pone.0002039.g005
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phenomenon, in vitro scavenging of NO and O2 by Hbs in the
presence of a reduction system may give little insight into true
physiological function.
The ability of SynHb to substitute for flavoHb in E. coli during
NO challenge is the only characteristic that distinguishes any of
the hxHbs from the others. The lag in growth following GSNO
treatment suggests that an endogenous reductase with activity
Figure 6. Protection of the E. coli hmp mutant from NO by Mb and hxHbs. A. The growth (OD600) of wild type (AB1157) and the hmp mutant
(AB1000) E coli strains carrying Mb and hxHbs under control of the flavoHb promoter were measured after 14h in the absence and presence of 3 mM
GSNO. Photolyzed GSNO was also used as control. Only flavoHb (hmp) and SynHb are able to rescue the phenotype observed for the wild type strain.
The data are an average of the duplication of at least three independent experiments. B. Hemoglobin expression levels driven by the hmp promoter.
The values reported are the averaged maximum absorbance of the CO-difference spectra peak. Data are an average of two independent experiments.
C. NO consumption by different E. coli strains. Compared to flavoHb, the consumption by other Hbs is significantly slower. Data are an average of two
replications of six independent experiments. D. Growth curves of AG1000 strains transformed with pANX and expressing flavoHb and SynHb (average
of two independent experiments). In the absence of GSNO, no differences are observed between strains. In the presence of GSNO, there is no growth
in the strain transformed with pANX alone. With flavoHb, the growth is similar to the one without GSNO. In presence of SynHb, growth occurs but is
significantly retarded.
doi:10.1371/journal.pone.0002039.g006
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question of whether this reductase has a natural role in NO
detoxification in E. coli, or whether a homologous reductase is
present with similar activity in Synechocystis, is currently unan-
swered. Future studies identifying such a reductase would be taken
as support for a NOD function for SynHb but, more importantly,
this observation demonstrates the potential use of E. coli AG1000
as a background for reductase screening in co-expression
experiments. Co-expression of a reductase (or library containing
a reductase) along with a Hb in AG1000 could identify Hb/
reductase pairs that are capable of replacing FlavoHb, thus
providing targets for identification of cognate reductases for Hbs
suspected of providing NOD activity in their native hosts.
In conclusion, the present study has evaluated the capacity of
hxHbs to serve as NOD enzymes by testing their abilities to react
with NO in the oxyferrous and ferric states, to scavenge NO in an
artificial reduction system where the rate of reduction is controlled
experimentally, and to replace flavoHb in vivo under aerobic
conditions. Our results demonstrate that these Hbs have a common
ability to react rapidly with NO in the oxyferrous state, and that they
will subsequently scavenge NO at a rate limited by re-reduction. It is
alsoclearthat reaction ofthe ferrichxHbs with NOare probably not
of physiological significance. These results are not contradictory to a
roleinNOscavenging,butneitherdotheypreferentiallysupportthis
hypothesis for any particular hxHb. Instead, they serve to focus
research in this area on identification of cognate reductases for each
Hb within their natural environments.
Supporting Information
Figure S1 Photolysis inactivation of GSNO
Found at: doi:10.1371/journal.pone.0002039.s001 (0.84 MB TIF)
Acknowledgments
We thank Dr. Paul Gardner from the Division of Critical Care Medicine,
Children’s Hospital Medical Center (Cincinnati, OH), for the E. coli strains
and the pANX plasmid.
Author Contributions
Conceived and designed the experiments: MH JT BS. Performed the
experiments: BS. Analyzed the data: MH JT BS. Contributed reagents/
materials/analysis tools: MH JT BS. Wrote the paper: MH JT BS. Other:
Principal Investigator, edited paper, designed, analysed, interpreted
experiments: MH. Performed all experiments, wrote main draft of
manuscript: BS. Extensive editorial, conceptual modification to manu-
script: JT. Analysis and interpretation of data, experimental design: JT.
References
1. Wittenberg JB (1965) Myoglobin-facilitated diffusion of oxygen. J Gen Phys 49:
57–74.
2. Antonini E, Brunori M (1971) Hemoglobin and Myoglobin in their Reactions
with Ligands; Neuberger A, Tatum EL, editors. Amsterdam: North-Holland
Publishing Company.
3. Antonini E (1965) Interrelationship Between Structure and Function in
Hemoglobin and Myoglobin. Physiol Rev 45: 123–170.
4. Jia L, Bonaventura C, Bonaventura J, Stamler J (1996) S-nitrosohaemoglobin: a
dynamic activity of blood involved in vascular control. Nature 380: 221–226.
5. Doherty D, Doyle MP, Curry SR, Vali R, Fattor T, et al. (1998) The Rate of
Reaction with NO Determines the Hypertensive Effect of Cell-free Hemoglobin.
Nature Biotech 16: 672–676.
6. Flogel U, Merx MW, Godecke A, Decking UKM, Schrader J (2001) Myoglobin:
A scavenger of bioactive NO. PNAS 98: 735–740.
7. Brunori M (2001) Nitric oxide moves myoglobin centre stage. TIBS 26: 209–210.
8. Wittenberg JB, Bolognesi M, Wittenberg BA, Guertin M (2002) Truncated
Hemoglobins: A New Family of Hemoglobins Widely Distributed in Bacteria,
Unicellular Eukaryotes, and Plants. J Biol Chem 277: 871–874.
9. Burmester T, Weich B, Reinhardt S, Hankeln T (2000) A vertebrate globin
expressed in the brain. Nature 407: 520–523.
10. Appleby C (1992) The origin and functions of hemoglobin in plants. Sci Progress
76: 365–398.
11. Trent JT III, Hargrove MS (2002) A Ubiquitously Expressed Human
Hexacoordinate Hemoglobin. J Biol Chem 277: 19538–19545.
12. Trent JT III, Watts RA, Hargrove MS (2001) Human neuroglobin, a
hexacoordinate hemoglobin that reversibly binds oxygen. J Biol Chem 276:
30106–30110.
13. Hargrove MS, Brucker EA, Stec B, Sarath G, Arredondo-Peter R, et al. (2000)
Crystal structure of a nonsymbiotic plant hemoglobin. Structure 8: 1005–1014.
14. Kundu S, Trent JT III, Hargrove MS (2003) Plants, humans and hemoglobins.
Trends in Plant Science 8: 387–393.
15. Burmester T, Ebner B, Weich B, Hankeln T (2002) Cytoglobin: A Novel Globin
Type Ubiquitously Expressed inVertebrate Tissues. Mol Biol Evol 19: 416–421.
16. Dewilde S, Kiger L, Burmester T, Hankeln T, Baudin-Creuza V, et al. (2001)
Biochemical Characterization and Ligand Binding Properties of Neuroglobin, a
Novel Member of the Globin Family. J Biol Chem 276: 38949–38955.
17. Awenius C, Hankeln T, Burmester T (2001) Neuroglobins from the Zebrafish
Danio rerio and the Pufferfish Tetraodon nigroviridis. Biochem Biophys Res
Commun 287: 418–421.
18. Scott NL, Falzone CJ, Vuletich DA, Zhao J, Bryant DA, et al. (2002) Truncated
Hemoglobin from the Cyanobacterium Synechococcus sp. PCC 7002: Evidence for
Hexacoordination and Covalent Adduct Formation in the Ferric Recombinant
Protein. Biochemistry 41: 6902–6910.
19. Hvitved AN, Trent JT III, Premer SA, Hargrove MS (2001) Ligand binding and
hexacoordination in Synechocystis hemoglobin. J Biol Chem 276: 34714–34721.
20. Trent JT, III, Hvitved AN, Hargrove MS (2001) A Model for Ligand Binding to
Hexacoordinate Hemoglobins. Biochemistry 40: 6155–6163.
21. Hargrove MS (2000) A flash photolysis method to characterize hexacoordinate
hemoglobin kinetics. Biophys J 79: 2733–2738.
22. Smagghe BJ, Sarath G, Ross E, Hilbert J-l, Hargrove MS (2006) Slow Ligand
Binding Kinetics Dominate Ferrous Hexacoordinate Hemoglobin Reactivities and
Reveal Differences between Plants and Other Species. Biochemistry 45: 561–570.
23. Hoy JA, Kundu S, Trent JT III, Ramaswamy S, Hargrove MS (2004) The
Crystal Structure of Synechocystis Hemoglobin with a Covalent Heme Linkage.
J Biol Chem 279: 16535–16542.
24. Pesce A, Dewilde S, Nardini M, Moens L, Ascenzi P, et al. (2003) Human brain
neuroglobin structure reveals a distinct mode of controlling oxygen affinity.
Structure 9: 1087–1095.
25. de Sanctis D, Dewilde S, Pesce A, Moens L, Ascenzi P, et al. (2004) Crystal
Structure of Cytoglobin: The Fourth Globin Type Discovered in Man Displays
Heme Hexa-coordination. Journal of Molecular Biology 336: 917–927.
26. Hankeln T, Ebner B, Fuchs C, Gerlach F, Haberkamp M, et al. (2005)
Neuroglobin and cytoglobin in search of their role in the vertebrate globin
family. Journal of Inorganic Biochemistry 99: 110–119.
27. Olson JS, Phillips GN Jr (1997) Myoglobin discriminates between O2, NO, and
CO by electrostatic interactions with the bound ligand. J Biol Inorg Chem 2:
544–552.
28. Sakamoto A, Sakurao S-h, Fukunaga K, Matsubara T, Ueda-Hashimoto M, et
al. (2004) Three distinct Arabidopsis hemoglobins exhibit peroxidase-like activity
and differentially mediate nitrite-dependent protein nitration. FEBS Letters 572:
27–32.
29. Kawada N, Kristensen D, Asahina K, Nakatani K, Minamiyama Y, et al. (2001)
Characterization of a stellate cell activation-associated protein (STAP) with
peroxidase activity found in rat hepatic stellate cells. J Biol Chem 276:
25318–25323.
30. Sun Y, Jin K, Mao XO, Zhu Y, Greenberg DA (2001) Neuroglobin is up-
regulated by and protects neurons from hypoxic-ischemic injury. Proc Natl Acad
Sci USA 98: 15306–15311.
Table 2. In vivo expression and NO consumption
Relative Expression Averaged
maximum absorbance (CO
difference spectrum peak)
NO consumption (mM/min/
10
7cells)
Hmp 0.12 0.98
Mb 0.33 0.23
RiceHb1 0.07 0.23
Ngb 0.005 0.055
Cgb 0.03 0.07
SynHb 0.33/0.28
* 0.11/0.58
*
*: value after overnight treatment with 3 mM GSNO
doi:10.1371/journal.pone.0002039.t002
NOD Activity and Hemoglobins
PLoS ONE | www.plosone.org 9 April 2008 | Volume 3 | Issue 4 | e203931. Sun Y, Jin K, Peel A, Mao XO, Xie L, et al. (2003) Neuroglobin protects the
brain from experimental stroke invivo. Proc Natl Acad Sci USA 100:
3497–3500.
32. Weber RE, Fago A (2004) Functional adaptation and its molecular basis in
vertebrate hemoglobins, neuroglobins and cytoglobins. Respiratory Physiology
& Neurobiology 144: 141–159.
33. Perazzolli M, Romero-Puertas MC, Delledonne M (2006) Modulation of nitric
oxide bioactivity by plant haemoglobins. J Exp Bot 57: 479–488.
34. Igamberdiev AU, Hill RD (2004) Nitrate, NO and haemoglobin in plant
adaptation to hypoxia: an alternative to classic fermentation pathways. J Exp Bot
408: 2473–2482.
35. Brunori M, Giuffre A, Nienhaus K, Nienhaus GU, Scandurra FM, et al. (2005)
Neuroglobin, nitric oxide, and oxygen: Functional pathways and conformational
changes. Proc Natl Acad Sci USA. pp 8483–8488.
36. Minning D, Gow A, Bonaventura J, Braun R, Dewhirst M, et al. (1999) Ascaris
haemoglobin is a nitric oxide-activated ‘deoxygenase’. Nature 401: 497–502.
37. Van Doorslaer S, Dewilde S, Kiger L, Nistor SV, Goovaerts E, et al. (2003)
Nitric Oxide Binding Properties of Neuroglobin. A CHARACTERIZATION
BY EPR AND FLASH PHOTOLYSIS. J Biol Chem 278: 4919–4925.
38. Herold S, Fago A, Weber RE, Dewilde S, Moens L (2004) Reactivity Studies of
the Fe(III) and Fe(II)NO Forms of Human Neuroglobin Reveal a Potential Role
against Oxidative Stress. J Biol Chem 279: 22841–22847.
39. Herold S, Fago A (2005) Reactions of peroxynitrite with globin proteins and
their possible physiological role. Comparative Biochemistry and Physiology 142:
124–129.
40. Eich RF, Li T, Lemon DD, Doherty DH, Curry SR, et al. (1996) Mechanism of
NO-induced oxidation of myoglobin and hemoglobin. Biochemistry 35:
6976–6983.
41. Olson JS, Foley EW, Rogge C, Tsai A-L, Doyle MP, et al. (2004) NO scavenging
and the hypertensive effect of hemoglobin-based blood substitutes. Free Rad Biol
Med 36: 685–697.
42. Gardner PR, Gardner AM, Martin LA, Salzman AL (1998) Nitric oxide
dioxygenase: an enzymatic function for flavohemoglobin. Proc Natl Acad Sci
USA 95: 10378–10383.
43. Gardner PR, Gardner AM, Martin LA, Dou Y, Li T, et al. (2000) Nitric-oxide
dioxygenase activity and function of flavohemoglobins. Sensitivity to nitric oxide
and carbon monoxide inhibition. J Biol Chem 275: 31581–31587.
44. Gardner AM, Martin LA, Gardner PR, Dou Y, Olson JS (2000) Steady-state
and transient kinetics of Escherichia coli nitric-oxide dioxygenase (Flavohemoglo-
bin). The B10 tyrosine hydroxyl is essential for dioxygen binding and catalysis.
J Biol Chem 275: 12581–12589.
45. Gardner PR (2005) Nitric oxide dioxygenase function and mechanism of
flavohemoglobin, hemoglobin, myoglobin and their associated reductases.
Journal of Inorganic Biochemistry 99: 247–266.
46. Gardner PR, Gardner AM, Brashear WT, Suzuki T, Hvitved AN, et al. (2006)
Hemoglobins dioxygenate nitric oxide with high fidelity. Journal of Inorganic
Biochemistry 100: 542–550.
47. Hausladen A, Gow A, Stamler JS (2001) Flavohemoglobin denitrosylase
catalyzes the reaction of a nitroxyl equivalent with molecular oxygen. Proc
Natl Acad Sci U S A 98: 10108–10112.
48. Herold S, Rock G (2005) Mechanistic Studies of the Oxygen-Mediated
Oxidation of Nitrosylhemoglobin. Biochemistry 44: 6223–6231.
49. Gonc ¸alves VL, Nobre LS, Vicente JB, Teixeira M, Saraiva LM (2006)
Flavohemoglobin requires microaerophilic conditions for nitrosative protection
of Staphylococcus aureus. FEBS letters 580: 1817–1821.
50. Zhu H, Riggs AF (1992) Yeast Flavohemoglobin is an ancient protein related to
globins and a reductase family. Proc Natl Acad Sci USA 89: 5015–5019.
51. Hardison RC (1996) A brief history of hemoglobins: Plant, animal, protist, and
bacteria. Proc Natl Acad Sci USA 93: 5675–5679.
52. Ilari A, Johnson KA, Bonamore A, Farina A, Boffi A (2002) The X-ray structure
of ferric Escherichia coli flavohemoglobin reveals an unexpected geometry of the
distal heme pocket. J Biol Chem 277: 23725–23732.
53. Franzen S (2002) An Electrostatic Model for the Frequency Shifts in the
Carbonmonoxy Stretching Band of Myoglobin: Correlation of Hydrogen
Bonding and the Stark Tuning Rate. J Amer Chem Soc 124: 13271–13281.
54. Gardner PR (2008) Assay and Characterization of the NO Dioxygenase Activity
of Flavohemoglobins. Methods Enzymol 436C: 217–237.
55. Weiland TR, Kundu S, Trent JT III, Hoy JA, Hargrove MS (2004) Bis-histidyl
hexacoordination in hemoglobins facilitates heme reduction kinetics. J Am
Chem Soc 126: 11930–11935.
56. Fago A, Mathews AJ, Moens L, Dewilde S, Brittain T (2006) The reaction of
neuroglobin with potential redox protein partners cytochrome b5 and
cytochrome c. FEBS letters 580: 4884–4888.
57. Trandafira F, Hoogewijsc D, Altierid F, Rivetti di Val Cervod P, Ramsere K, et
al. (2007) Neuroglobin and cytoglobin as potential enzyme or substrate. Gene
398: 103–113.
58. Schmidt M, Giessl A, Laufs T, Hankeln T, Wolfrum U, et al. (2003) How Does
the Eye Breathe? EVIDENCE FOR NEUROGLOBIN-MEDIATED OXY-
GEN SUPPLY IN THE MAMMALIAN RETINA. J Biol Chem 278:
1932–1935.
59. Ford PC, Fernandez BO, Lim MD (2005) Mechanisms of Reductive
Nitrosylation in Iron and Copper Models Relevant to Biological Systems.
Chem Rev 105: 2439–2456.
60. Gardner PR, Costantino G, Szabo C, Salzman AL (1997) Nitric Oxide
Sensitivity of the Aconitases. J Biol Chem 272: 25071–25076.
61. Hayashi A, Suzuki T, Shin M (1973) An enzymic reduction system for
metmyoglobin and methemoglobin, and its application to functional studies of
oxygen carriers. Biochim Biophys Acta 310: 309–316.
62. Helmick RA, Fletcher AE, Gardner AM, Gessner CR, Hvitved AN, et al. (2005)
Imidazole Antibiotics Inhibit the Nitric Oxide Dioxygenase Function of
Microbial Flavohemoglobin. Antimicrob Agents Chemother 49: 1837–1843.
63. Stamler JS, Loscalzo J (1992) Capillary Zone Electrophoretic Detection of
Biological Thiols and Their S-Nitrosated Derivatives. Analytical Chemistry 64:
779–785.
64. Hogg N, Singh RJ, Kalyanaraman B (1996) The role of glutathione in the
transport and catabolism of nitric oxide. FEBS Letters 382: 223–228.
65. Singh RJ, Hogg N, Joseph J, Kalyanaraman B (1996) Mechanism of Nitric
Oxide Release from S-Nitrosothiols. J Biol Chem 271: 18596–18603.
66. Herold S, Exner M, Nauser T (2001) Kinetic and mechanistic studies of the
NO(*)-mediated oxidation of oxymyoglobin and oxyhemoglobin. Biochemistry
40: 3385–3395.
67. Dordas C, Hasinoff B, Rivoal J, Hill RD (2004) Class-1 hemoglobins, nitrate and
NO levels in anoxic maize cell-suspension cultures. Planta 219: 66–72.
68. Perazzolli M, Dominici P, Romero-Puertas MC, Zago E, Zeier J, et al. (2004)
Arabidopsis Nonsymbiotic Hemoglobin AHb1 Modulates Nitric Oxide
Bioactivity. Plant Cell 16: 2785–2794.
69. Fernandez BO, Lorkovic IM, Ford PC (2004) Mechanisms of Ferriheme
Reduction by Nitric Oxide: Nitrite and General Base Catalysis
1. Inorg Chem 43:
5393–5402.
70. Liu L, Zeng M, Hausladen A, Heitman J, Stamler J (2000) Protection from
nitrosative stress by yeast flavohemoglobin. Proc Natl Acad Sci USA 97:
4672–4676.
71. Frey AD, Farres J, Bollinger CJT, Kallio PT (2002) Bacterial Hemoglobins and
Flavohemoglobins for Alleviation of Nitrosative Stress in Escherichia coli. Appl
Environ Microbiol 68: 4835–4840.
72. Ouellet H, Ouellet Y, Richard C, Labarre M, Wittenberg B, et al. (2002)
Truncated hemoglobin HbN protects Mycobacterium bovis from nitric oxide.
Proc Natl Acad Sci USA 99: 5902–5907.
73. Pathania R, Navani NK, Gardner AM, Gardner PR, Dikshit KL (2002) Nitric
oxide scavenging and detoxification by the Mycobacterium tuberculosis
haemoglobin, HbN in Escherichia coli. Molecular Microbiology 45: 1303–1314.
74. Gardner AM, Gardner PR (2002) Flavohemoglobin Detoxifies Nitric Oxide in
Aerobic, but Not Anaerobic, Eschericia coli. J Biol Chem 277: 8166–8171.
75. Vidwans AS, Kim S, Coffin DO, Wink DA, Hewett SJ (1999) Analysis of the
Neuroprotective Effects of Various NitricOxide Donor Compounds in Murine
Mixed Cortical Cell Culture. Journal of Neurochemistry 72: 1843–1852.
76. Membrillo-Hernandez J, Coopamah MD, Anjum MF, Stevanin TM, Kelly A, et
al. (1999) The flavohemoglobin of Escherichia coli confers resistance to a
nitrosating agent, a ‘‘Nitric oxide Releaser,’’ and paraquat and is essential for
transcriptional responses to oxidative stress. J Biol Chem 274: 748–754.
77. Membrillo-Hernandez J, Coopamah MD, Channa A, Hughes MN, Poole RK
(1998) A novel mechanism for upregulation of the Escherichia coli K-12 hmp
(flavohaemoglobin) gene by the ‘NO releaser’, S-nitrosoglutathione: nitrosation
of homocysteine and modulation of MetR binding to the glyA-hmp intergenic
region. Molecular Microbiology 29: 1101–1112.
78. Flatley J, Barrett J, Pullan ST, Hughes MN, Green J, et al. (2005)
Transcriptional Responses of Escherichia coli to S-Nitrosoglutathione under
Defined Chemostat Conditions Reveal Major Changes in Methionine
Biosynthesis. J Biol Chem 280: 10065–10072.
79. Kaur R, Pathania R, Sharma V, Mande SC, Dikshit KL (2002) Chimeric
Vitreoscilla Hemoglobin (VHb) Carrying a Flavoreductase Domain Relieves
Nitrosative Stress in Escherichia coli: New Insight into the Functional Role of
VHb. Appl Environ Microbiol 68: 152–160.
80. Hernandez-Urzua E, Mills CE, White GP, Contreras-Zentella ML, Escamilla E,
et al. (2003) Flavohemoglobin Hmp, but Not Its Individual Domains, Confers
Protection from Respiratory Inhibition by Nitric Oxide in Escherichia coli. J Biol
Chem 278: 34975–34982.
81. Halder P, Trent JT III, Hargrove MS (2006) The Influence of the Protein
Matrix on Histidine Ligation in Ferric and Ferrous Hexacoordinate Hemoglo-
bins. PROTEINS: Structure, Function, and Bioinformatics.
82. Lopez-Barneo J, Pardal R, Ortega-Saenz P (2001) Cellular mechanism of
oxygen sensing. Annu Rev Physiol 63: 259–287.
83. Ledo AFF, Barbosa R, Laranjinha J (2004) Nitric oxide in brain: diffusion,
targets and concentration dynamics in hippocampal subregions. Molecular
Aspects of Medicine 24: 75–89.
84. Igamberdiev A, Bykova N, Hill R (2006) Nitric oxide scavenging by barley
hemoglobin is facilitated by a monodehydroascorbate reductase-mediated
ascorbate reduction of methemoglobin. Planta 223: 1033–1040.
85. Jakob W, Webster D, Kroneck P (1992) NADH-dependent methemoglobin
reductase from the obligate aerobe Vitreoscilla: improved method of purification
and reexamination of prosthetic groups. Arch Biochem Biophys 292: 29–33.
86. Brown WD, Snyder HE (1969) Nonenzymatic Reduction and Oxidation of
Myoglobin and Hemoglobin by Nicotinamide Adenine Dinucleotides and
Flavins. J Biol Chem 244: 6702–6706.
NOD Activity and Hemoglobins
PLoS ONE | www.plosone.org 10 April 2008 | Volume 3 | Issue 4 | e2039